Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
HiFiBiO Therapeutics
Seattle Children's Hospital
Seattle Children's Hospital
Tango Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
Sarcoma Alliance for Research through Collaboration
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Valo Therapeutics Oy
Instituto do Cancer do Estado de São Paulo
Cybrexa Therapeutics
Actuate Therapeutics Inc.
Shanghai PerHum Therapeutics Co., Ltd.
Gustave Roussy, Cancer Campus, Grand Paris
Adaptimmune